Biobanking Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global biobanking market looks promising with opportunities in regenerative medicine, life science research, and clinical research applications. The global biobanking market is expected to grow with a CAGR of 4%-6% from 2020 to 2025. The major drivers for this market are increasing research activities related to genomic, rising demand for cost effective drug discovery and development, and favorable government initiatives to support regenerative medicine research.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global biobanking market report, please download the report brochure.
biobanking
In this market, equipment is the largest product and service segment of biobanking, whereas regenerative medicine is the largest application. Growth in various segments of the biobanking market are given below:
biobanking
The study includes trends and forecast for the global biobanking market by product and service, sample type, storage type, biobank type, ownership, application, and region as follows:
By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:
EquipmentConsumablesServicesSoftware
By Sample Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Blood ProductsHuman TissueCell LinesNucleic AcidsBiological FluidsHuman Waste Products
By Storage Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Manual StorageAutomated Storage
By Biobank Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Population Based BiobanksDisease- Oriented Biobanks
By Ownership [Value ($ Million) shipment analysis for 2014 – 2025]:
National/Regional AgenciesNonprofit OrganizationsUniversitiesPrivate Organizations
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Regenerative MedicineLife Science ResearchClinical Research
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the World Brazil
Some of the biobanking companies profiled in this report include Askion, CTI Biotech, Cureline, Excilone, Firalis, Hamilton, LabVantage Solutions, LGC, PrecisionMed, and ProMedDx.
Lucintel forecasts that equipment will remain the largest product and service segment over the forecast period due to an increasing number of biosamples to be stored and growing number of biobanks.
Within this market, regenerative medicine will remain the largest application segment over the forecast period due to increasing research activities related to regenerative medicine and rising demand for well characterized and quality biosamples for research.
North America will remain the largest region over the forecast period due to increasing research and development expenditure and developed healthcare infrastructure in the region.
Features of the Global Biobanking Market
Market Size Estimates: Global biobanking market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global biobanking market size by various segments, such as product and service, sample type, storage type, biobank type, ownership, and application in terms of value.Regional Analysis: Global biobanking market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product and service, sample type, storage type, biobank type, ownership, and application, and region for the global biobanking market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global biobanking market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global biobanking market by product and service (equipment, consumables, services, and software), sample type (blood products, human tissue, cell lines, nucleic acids, biological fluids, and human waste products), storage type (manual storage and automated storage), biobank type (population based biobanks and disease- oriented biobanks), ownership (national/regional agencies, nonprofit organizations, universities, and private organizations), application (regenerative medicine, life science research, and clinical research) and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global biobanking market?
Q.5 What are the business risks and threats to the global biobanking market?
Q.6 What are the emerging trends in this biobanking market and the reasons behind them?
Q.7 What are some changing demands of customers in this biobanking market?
Q.8 What are the new developments in this biobanking market? Which companies are leading these developments?
Q.9 Who are the major players in this biobanking market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this biobanking market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global biobanking market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product And Service (Equipment, Consumables, Services, and Software), Sample Type (Blood Products, Human Tissue, Cell Lines, Nucleic Acids, Biological Fluids, and Human Waste Products), Storage Type (Manual Storage and Automated Storage), Biobank Type (Population Based Biobanks and Disease- Oriented Biobanks), Ownership (National/Regional Agencies, Nonprofit Organizations, Universities, and Private Organizations), and Application (Regenerative Medicine, Life Science Research, and Clinical Research)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global biobanking market looks promising with opportunities in regenerative medicine, life science research, and clinical research applications. The global biobanking market is expected to grow with a CAGR of 4%-6% from 2020 to 2025. The major drivers for this market are increasing research activities related to genomic, rising demand for cost effective drug discovery and development, and favorable government initiatives to support regenerative medicine research.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global biobanking market report, please download the report brochure.
biobanking
In this market, equipment is the largest product and service segment of biobanking, whereas regenerative medicine is the largest application. Growth in various segments of the biobanking market are given below:
biobanking
The study includes trends and forecast for the global biobanking market by product and service, sample type, storage type, biobank type, ownership, application, and region as follows:
By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:
EquipmentConsumablesServicesSoftware
By Sample Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Blood ProductsHuman TissueCell LinesNucleic AcidsBiological FluidsHuman Waste Products
By Storage Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Manual StorageAutomated Storage
By Biobank Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Population Based BiobanksDisease- Oriented Biobanks
By Ownership [Value ($ Million) shipment analysis for 2014 – 2025]:
National/Regional AgenciesNonprofit OrganizationsUniversitiesPrivate Organizations
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Regenerative MedicineLife Science ResearchClinical Research
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the World Brazil
Some of the biobanking companies profiled in this report include Askion, CTI Biotech, Cureline, Excilone, Firalis, Hamilton, LabVantage Solutions, LGC, PrecisionMed, and ProMedDx.
Lucintel forecasts that equipment will remain the largest product and service segment over the forecast period due to an increasing number of biosamples to be stored and growing number of biobanks.
Within this market, regenerative medicine will remain the largest application segment over the forecast period due to increasing research activities related to regenerative medicine and rising demand for well characterized and quality biosamples for research.
North America will remain the largest region over the forecast period due to increasing research and development expenditure and developed healthcare infrastructure in the region.
Features of the Global Biobanking Market
Market Size Estimates: Global biobanking market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global biobanking market size by various segments, such as product and service, sample type, storage type, biobank type, ownership, and application in terms of value.Regional Analysis: Global biobanking market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product and service, sample type, storage type, biobank type, ownership, and application, and region for the global biobanking market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global biobanking market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global biobanking market by product and service (equipment, consumables, services, and software), sample type (blood products, human tissue, cell lines, nucleic acids, biological fluids, and human waste products), storage type (manual storage and automated storage), biobank type (population based biobanks and disease- oriented biobanks), ownership (national/regional agencies, nonprofit organizations, universities, and private organizations), application (regenerative medicine, life science research, and clinical research) and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global biobanking market?
Q.5 What are the business risks and threats to the global biobanking market?
Q.6 What are the emerging trends in this biobanking market and the reasons behind them?
Q.7 What are some changing demands of customers in this biobanking market?
Q.8 What are the new developments in this biobanking market? Which companies are leading these developments?
Q.9 Who are the major players in this biobanking market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this biobanking market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global biobanking market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product And Service (Equipment, Consumables, Services, and Software), Sample Type (Blood Products, Human Tissue, Cell Lines, Nucleic Acids, Biological Fluids, and Human Waste Products), Storage Type (Manual Storage and Automated Storage), Biobank Type (Population Based Biobanks and Disease- Oriented Biobanks), Ownership (National/Regional Agencies, Nonprofit Organizations, Universities, and Private Organizations), and Application (Regenerative Medicine, Life Science Research, and Clinical Research)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Biobanking Market Trends and Forecast
3.3: Global Biobanking Market by Product and Service
3.3.1: Equipment
3.3.2: Consumables
3.3.3: Services
3.3.4: Software
3.4: Global Biobanking Market by Sample Type
3.4.1: Blood Products
3.4.2: Human Tissue
3.4.3: Cell Lines
3.4.4: Nucleic Acids
3.4.5: Biological Fluids
3.4.6: Human Waste Products
3.5: Global Biobanking Market by Storage Type
3.5.1: Manual Storage
3.5.2: Automated Storage
3.6: Global Biobanking Market by Biobank Type
3.6.1: Population Based Biobanks
3.6.2: Disease- Oriented Biobanks
3.7: Global Biobanking Market by Ownership
3.7.1: National/Regional Agencies
3.7.2: Nonprofit Organizations
3.7.3: Universities
3.7.4: Private Organizations
3.8: Global Biobanking Market by Application
3.8.1: Regenerative Medicine
3.8.2: Life Science Research
3.8.3: Clinical Research
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Biobanking Market by Region
4.2: North American Biobanking Market
4.2.1: Market by Product and Service: Equipment, Consumables, Services, and Software
4.2.2: Market by Sample Type: Blood Products, Human Tissue, Cell Lines, Nucleic Acids, Biological Fluids, and Human Waste Products
4.2.3: Market by Storage Type: Manual Storage and Automated Storage
4.2.4: Market by Biobank Type: Population Based Biobanks and Disease- Oriented Biobanks
4.2.5: Market by Ownership: National/Regional Agencies, Nonprofit Organizations, Universities, and Private Organizations
4.2.6: Market by Application: Regenerative Medicine, Life Science Research, and Clinical Research
4.2.7: The United States Biobanking Market
4.2.8: The Canadian Biobanking Market
4.2.9: The Mexican Biobanking Market
4.3: European Biobanking Market
4.3.1: Market by Product and Service: Equipment, Consumables, Services, and Software
4.3.2: Market by Sample Type: Blood Products, Human Tissue, Cell Lines, Nucleic Acids, Biological Fluids, and Human Waste Products
4.3.3: Market by Storage Type: Manual Storage and Automated Storage
4.3.4: Market by Biobank Type: Population Based Biobanks and Disease- Oriented Biobanks
4.3.5: Market by Ownership: National/Regional Agencies, Nonprofit Organizations, Universities, and Private Organizations
4.3.6: Market by Application: Regenerative Medicine, Life Science Research, and Clinical Research
4.3.7: The Biobanking Market of United Kingdom
4.3.8: The German Biobanking Market
4.3.9: The French Biobanking Market
4.4: APAC Biobanking Market
4.4.1: Market by Product and Service: Equipment, Consumables, Services, and Software
4.4.2: Market by Sample Type: Blood Products, Human Tissue, Cell Lines, Nucleic Acids, Biological Fluids, and Human Waste Products
4.4.3: Market by Storage Type: Manual Storage and Automated Storage
4.4.4: Market by Biobank Type: Population Based Biobanks and Disease- Oriented Biobanks
4.4.5: Market by Ownership: National/Regional Agencies, Nonprofit Organizations, Universities, and Private Organizations
4.4.6: Market by Application: Regenerative Medicine, Life Science Research, and Clinical Research
4.4.7: The Chinese Biobanking Market
4.4.8: The Indian Biobanking Market
4.4.9: The Japanese Biobanking Market
4.5: ROW Biobanking Market
4.5.1: Market by Product and Service: Equipment, Consumables, Services, and Software
4.5.2: Market by Sample Type: Blood Products, Human Tissue, Cell Lines, Nucleic Acids, Biological Fluids, and Human Waste Products
4.5.3: Market by Storage Type: Manual Storage and Automated Storage
4.5.4: Market by Biobank Type: Population Based Biobanks and Disease- Oriented Biobanks
4.5.5: Market by Ownership: National/Regional Agencies, Nonprofit Organizations, Universities, and Private Organizations
4.5.6: Market by Application: Regenerative Medicine, Life Science Research, and Clinical Research
4.5.7: Brazilian Biobanking Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Biobanking Market by Product and Service
7.1.2: Growth Opportunities for the Global Biobanking Market by Sample Type
7.1.3: Growth Opportunities for the Global Biobanking Market by Storage Type
7.1.3: Growth Opportunities for the Global Biobanking Market by Biobank Type
7.1.3: Growth Opportunities for the Global Biobanking Market by Ownership
7.1.3: Growth Opportunities for the Global Biobanking Market by Application
7.1.4: Growth Opportunities for the Global Biobanking Market by Region
7.2: Emerging Trends in the Global Biobanking Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Biobanking Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biobanking Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Askion GmbH
8.2: CTI Biotech
8.3: Cureline, Inc.
8.4: Excilone SARL
8.5: Firalis S.A.
8.6: Hamilton Company
8.7: LabVantage Solutions, Inc.
8.8: LGC Limited
8.9: PrecisionMed, Inc.
8.10: ProMedDx, LLC
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Biobanking Market Trends and Forecast
3.3: Global Biobanking Market by Product and Service
3.3.1: Equipment
3.3.2: Consumables
3.3.3: Services
3.3.4: Software
3.4: Global Biobanking Market by Sample Type
3.4.1: Blood Products
3.4.2: Human Tissue
3.4.3: Cell Lines
3.4.4: Nucleic Acids
3.4.5: Biological Fluids
3.4.6: Human Waste Products
3.5: Global Biobanking Market by Storage Type
3.5.1: Manual Storage
3.5.2: Automated Storage
3.6: Global Biobanking Market by Biobank Type
3.6.1: Population Based Biobanks
3.6.2: Disease- Oriented Biobanks
3.7: Global Biobanking Market by Ownership
3.7.1: National/Regional Agencies
3.7.2: Nonprofit Organizations
3.7.3: Universities
3.7.4: Private Organizations
3.8: Global Biobanking Market by Application
3.8.1: Regenerative Medicine
3.8.2: Life Science Research
3.8.3: Clinical Research
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Biobanking Market by Region
4.2: North American Biobanking Market
4.2.1: Market by Product and Service: Equipment, Consumables, Services, and Software
4.2.2: Market by Sample Type: Blood Products, Human Tissue, Cell Lines, Nucleic Acids, Biological Fluids, and Human Waste Products
4.2.3: Market by Storage Type: Manual Storage and Automated Storage
4.2.4: Market by Biobank Type: Population Based Biobanks and Disease- Oriented Biobanks
4.2.5: Market by Ownership: National/Regional Agencies, Nonprofit Organizations, Universities, and Private Organizations
4.2.6: Market by Application: Regenerative Medicine, Life Science Research, and Clinical Research
4.2.7: The United States Biobanking Market
4.2.8: The Canadian Biobanking Market
4.2.9: The Mexican Biobanking Market
4.3: European Biobanking Market
4.3.1: Market by Product and Service: Equipment, Consumables, Services, and Software
4.3.2: Market by Sample Type: Blood Products, Human Tissue, Cell Lines, Nucleic Acids, Biological Fluids, and Human Waste Products
4.3.3: Market by Storage Type: Manual Storage and Automated Storage
4.3.4: Market by Biobank Type: Population Based Biobanks and Disease- Oriented Biobanks
4.3.5: Market by Ownership: National/Regional Agencies, Nonprofit Organizations, Universities, and Private Organizations
4.3.6: Market by Application: Regenerative Medicine, Life Science Research, and Clinical Research
4.3.7: The Biobanking Market of United Kingdom
4.3.8: The German Biobanking Market
4.3.9: The French Biobanking Market
4.4: APAC Biobanking Market
4.4.1: Market by Product and Service: Equipment, Consumables, Services, and Software
4.4.2: Market by Sample Type: Blood Products, Human Tissue, Cell Lines, Nucleic Acids, Biological Fluids, and Human Waste Products
4.4.3: Market by Storage Type: Manual Storage and Automated Storage
4.4.4: Market by Biobank Type: Population Based Biobanks and Disease- Oriented Biobanks
4.4.5: Market by Ownership: National/Regional Agencies, Nonprofit Organizations, Universities, and Private Organizations
4.4.6: Market by Application: Regenerative Medicine, Life Science Research, and Clinical Research
4.4.7: The Chinese Biobanking Market
4.4.8: The Indian Biobanking Market
4.4.9: The Japanese Biobanking Market
4.5: ROW Biobanking Market
4.5.1: Market by Product and Service: Equipment, Consumables, Services, and Software
4.5.2: Market by Sample Type: Blood Products, Human Tissue, Cell Lines, Nucleic Acids, Biological Fluids, and Human Waste Products
4.5.3: Market by Storage Type: Manual Storage and Automated Storage
4.5.4: Market by Biobank Type: Population Based Biobanks and Disease- Oriented Biobanks
4.5.5: Market by Ownership: National/Regional Agencies, Nonprofit Organizations, Universities, and Private Organizations
4.5.6: Market by Application: Regenerative Medicine, Life Science Research, and Clinical Research
4.5.7: Brazilian Biobanking Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Biobanking Market by Product and Service
7.1.2: Growth Opportunities for the Global Biobanking Market by Sample Type
7.1.3: Growth Opportunities for the Global Biobanking Market by Storage Type
7.1.3: Growth Opportunities for the Global Biobanking Market by Biobank Type
7.1.3: Growth Opportunities for the Global Biobanking Market by Ownership
7.1.3: Growth Opportunities for the Global Biobanking Market by Application
7.1.4: Growth Opportunities for the Global Biobanking Market by Region
7.2: Emerging Trends in the Global Biobanking Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Biobanking Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biobanking Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Askion GmbH
8.2: CTI Biotech
8.3: Cureline, Inc.
8.4: Excilone SARL
8.5: Firalis S.A.
8.6: Hamilton Company
8.7: LabVantage Solutions, Inc.
8.8: LGC Limited
8.9: PrecisionMed, Inc.
8.10: ProMedDx, LLC
